№ lp_2_1_19584
File format: docx
Character count: 4048
File size: 19 KB
The document discusses the division of the consultation process on proposed changes to Oxfordshire health services into two phases, which is criticized for lacking essential information necessary for informed public opinion.
Year:
2017
Region / City:
Oxfordshire
Topic:
Health Services Consultation
Document Type:
Consultation Guide
Organization:
Oxfordshire Clinical Commissioning Group (OCCG)
Author:
Not specified
Target Audience:
Public, healthcare professionals, policymakers
Period of Action:
November 2017
Approval Date:
Not specified
Date of Changes:
January 27, 2017
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Republic of the Philippines
Theme:
Land reform, Stakeholder engagement, Agrarian reform
Document Type:
Stakeholder Engagement Plan
Organization:
Department of Agrarian Reform
Author:
Department of Agrarian Reform
Target Audience:
Agrarian reform beneficiaries, government agencies, civil society organizations, and other stakeholders
Period of Implementation:
Ongoing
Approval Date:
October 2024
Date of Last Revision:
N/A
Context:
A Stakeholder Engagement Plan for the SPLIT project detailing the parcelization process of collective land ownership titles for agrarian reform beneficiaries, aiming to engage stakeholders and ensure their participation in the project’s design and implementation.
Year:
2023
Region / City:
North America
Theme:
HVAC, Air Conditioning
Document Type:
Technical Specifications
Organization:
Daikin North America LLC
Author:
Daikin North America LLC
Target Audience:
Engineers, Contractors, HVAC Professionals
Warranty Period:
10 years
Performance Data:
Cooling: 7,200 - 60,000 Btu/h, Heating: 8,500 - 60,000 Btu/h
Date of Approval:
Not specified
Date of Changes:
Not specified
Note:
Year
Theme:
HVAC
Document Type:
Specification
Organization / Institution:
Daikin North America LLC
Target Audience:
Contractors, HVAC professionals
Year:
2026
Region / City:
North America
Topic:
HVAC Systems
Document Type:
Technical Specifications
Organization / Institution:
Daikin North America LLC
Author:
Daikin North America LLC
Target Audience:
HVAC engineers, contractors, and industry professionals
Period of validity:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2021
Region / city:
N/A
Topic:
Electrical Cable Jointing
Document type:
Instruction Manual
Organization / institution:
N/A
Author:
Atif Haq
Target audience:
SSEN staff
Period of validity:
N/A
Approval date:
14.12.21
Revision date:
11.11.21
Year:
2022
Region / city:
Toulouse, France
Topic:
5G, Network Architecture
Document type:
Change Request
Organization / institution:
3GPP
Author:
Qualcomm Incorporated
Target audience:
Network engineers, telecom industry professionals
Period of validity:
Not specified
Approval date:
2022-07-14
Modification date:
Not specified
Note:
Year
Topic:
HVAC
Document Type:
Technical Guide
Organization:
Samsung Electronics
Target Audience:
Engineers, HVAC Professionals
Year:
7
Region / City:
Not specified
Theme:
Islamic History, Religious Studies
Document Type:
Educational Lesson Plan
Institution:
Not specified
Author:
Thomas Nitz
Target Audience:
Students
Period of Use:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Region / city:
Australia
Subject:
Influenza Vaccination
Document Type:
Resubmission for listing
Agency / institution:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Sanofi-Aventis Australia Pty Ltd
Target Audience:
Healthcare providers, public health authorities
Period of validity:
From 2020 onward
Approval Date:
July 2019
Date of amendments:
July 2019
Year:
2017
Country:
Australia
Vaccine type:
Inactivated trivalent influenza vaccine (TIV-HD)
Manufacturer:
Sanofi-Aventis Australia Pty Ltd
Product form:
Suspension for injection, 180mcg single dose in 0.5mL
Regulatory approval:
TGA registration December 2017
Target population:
Persons aged 65 years and older
Purpose:
Listing on National Immunisation Program (NIP)
Comparative analysis:
Cost-minimisation versus standard quadrivalent influenza vaccine (QIV)
Advisory review:
PBAC and ATAGI evaluation
Implementation considerations:
Cold chain capacity, provider communication, monitoring adverse events
Note:
Year
Topic:
Insurance, Fire Protection
Document Type:
Questionnaire
Agency / organization:
National Casualty Company, Scottsdale Insurance Company, Scottsdale Indemnity Company, Scottsdale Surplus Lines Insurance Company
Target audience:
Insurance companies, property owners
Year:
2025-26
Region / City:
N/A
Subject:
Social Science
Type of document:
Educational syllabus
Organization:
Navy Children School
Author:
N/A
Target Audience:
Students of class VII
Period of Validity:
2025-26
Approval Date:
N/A
Date of Changes:
N/A
Year:
2016
Edition Date:
02/16
Manufacturer:
Carrier Corporation
Catalog Number:
GS-38AUQ-7-25-02PD
Replaces:
GS-38AUQ-7-25-01PD
System Type:
Air-cooled split system heat pump
Refrigerant:
Puron® (R-410A)
Capacity Range:
66,000 to 214,000 Btuh Heating / 6 to 20 Nominal Tons Cooling
Compliance Standards:
AHRI 340/360, ANSI/ASHRAE 15, NEC, UL 1995
Materials:
Galvanized steel cabinet, aluminum fins, copper tubes
Installation:
Outdoor, ground or rooftop
Controls:
Carrier PremierLink™, programmable thermostats, safety devices
Optional Features:
Low-ambient temperature control, pre-coated or E-coated coils, louvered hail guard package
Version:
V1.2
Revision date:
Mar 18, 2020
BOM:
31014128
Note:
Copyright by Vertiv Group Corp.
Romania:
800477000
Egypt, Bahrain:
390499717744
Croatia:
800989019
Greece:
80044146622
Qatar:
800100439
UAE:
800035702985
Ghana:
242426263
Saudi Arabia:
8008446628
Nigeria:
7080601125
Non-listed Countries:
49872327750
Turkey:
800448826888
(Austria, Benelux, Czech Republic, France, Germany, Hungary, Ireland, Italy, Poland, Russia, Spain, Sweden, Switzerland, UK, South Africa):
80011554499
Website:
www.vertiv.com
Year:
2026
Region / city:
United Kingdom
Topic:
Good Manufacturing Practice, Advanced Therapy Medicinal Products (ATMPs)
Document type:
Consultation response
Organization / institution:
NHS Advanced Therapy Medicinal Products Working Party
Author:
Anne Black
Target audience:
Pharmaceutical professionals, regulatory bodies, academic researchers
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2019
Region / City:
European Union
Topic:
PRIIPs Regulation amendments
Document Type:
Consultation Paper
Institution:
European Supervisory Authorities (ESAs)
Author:
European Supervisory Authorities (ESAs)
Target Audience:
Stakeholders in financial services and investments
Action Period:
16 October 2019 - 13 January 2020
Approval Date:
16 October 2019
Amendment Date:
Not specified
Year:
2026
Region / City:
Greater Manchester
Theme:
Healthcare, Pharmaceutical Recommendations
Document Type:
Report
Institution:
NHS Greater Manchester Medicines Management Group (GMMMG)
Author:
CRG (Clinical Reference Group)
Target Audience:
Healthcare professionals in the NHS
Period of validity:
Until 27th February 2026 (for specific drugs)
Approval Date:
13th January 2026
Date of Changes:
27th February 2026
Cost Impact:
£61,000 per year
Service Implications:
Transfer of prescribing to primary care, potential reduction in specialist service burden
Description:
Recommendations by the Clinical Reference Group (CRG) for the inclusion, continuation, or discontinuation of specific drugs, including azathioprine suspension and sotrovimab, in the Greater Manchester formulary.
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Year:
2019
Region / City:
Australia
Topic:
Recency of Practice for Registered Health Practitioners
Document Type:
Consultation Report
Organization / Institution:
National Boards (Aboriginal and Torres Strait Islander Health Practice Board of Australia, Chinese Medicine Board of Australia, Occupational Therapy Board of Australia)
Author:
National Boards
Target Audience:
Registered Health Practitioners
Period of Validity:
2019
Approval Date:
Not specified
Amendment Date:
Not specified
Context:
A consultation report detailing the review of recency of practice (RoP) registration standards for health practitioners in Australia, aiming to establish revised requirements to ensure ongoing professional competence.